These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 30685251

  • 21. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
    Miura K, Keister DB, Muratova OV, Sattabongkot J, Long CA, Saul A.
    Malar J; 2007 Aug 08; 6():107. PubMed ID: 17686163
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Differential ability of specific regions of Plasmodium falciparum sexual-stage antigen, Pfs230, to induce malaria transmission-blocking immunity.
    Bustamante PJ, Woodruff DC, Oh J, Keister DB, Muratova O, Williamson KC.
    Parasite Immunol; 2000 Aug 08; 22(8):373-80. PubMed ID: 10972844
    [Abstract] [Full Text] [Related]

  • 24. Sporozoite neutralizing antibodies elicited in mice and rhesus macaques immunized with a Plasmodium falciparum repeat peptide conjugated to meningococcal outer membrane protein complex.
    Przysiecki C, Lucas B, Mitchell R, Carapau D, Wen Z, Xu H, Wang XM, Nahas D, Wu C, Hepler R, Ottinger E, Ter Meulen J, Kaslow D, Shiver J, Nardin E.
    Front Cell Infect Microbiol; 2012 Aug 08; 2():146. PubMed ID: 23226683
    [Abstract] [Full Text] [Related]

  • 25. RTS,S/AS01E immunization increases antibody responses to vaccine-unrelated Plasmodium falciparum antigens associated with protection against clinical malaria in African children: a case-control study.
    Dobaño C, Ubillos I, Jairoce C, Gyan B, Vidal M, Jiménez A, Santano R, Dosoo D, Nhabomba AJ, Ayestaran A, Aguilar R, Williams NA, Díez-Padrisa N, Lanar D, Chauhan V, Chitnis C, Dutta S, Gaur D, Angov E, Asante KP, Owusu-Agyei S, Valim C, Gamain B, Coppel RL, Cavanagh D, Beeson JG, Campo JJ, Moncunill G.
    BMC Med; 2019 Aug 14; 17(1):157. PubMed ID: 31409398
    [Abstract] [Full Text] [Related]

  • 26. PRIMVAC vaccine adjuvanted with Alhydrogel or GLA-SE to prevent placental malaria: a first-in-human, randomised, double-blind, placebo-controlled study.
    Sirima SB, Richert L, Chêne A, Konate AT, Campion C, Dechavanne S, Semblat JP, Benhamouda N, Bahuaud M, Loulergue P, Ouédraogo A, Nébié I, Kabore M, Kargougou D, Barry A, Ouattara SM, Boilet V, Allais F, Roguet G, Havelange N, Lopez-Perez E, Kuppers A, Konaté E, Roussillon C, Kanté M, Belarbi L, Diarra A, Henry N, Soulama I, Ouédraogo A, Esperou H, Leroy O, Batteux F, Tartour E, Viebig NK, Thiebaut R, Launay O, Gamain B.
    Lancet Infect Dis; 2020 May 14; 20(5):585-597. PubMed ID: 32032566
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Accelerated and long term stability study of Pfs25-EPA conjugates adjuvanted with Alhydrogel®.
    Zhu D, Wu Y, McClellan H, Dai W, Rausch K, Jones D, Aebig J, Barnafo E, Butler B, Lambert L, Narum DL, Duffy PE.
    Vaccine; 2017 May 31; 35(24):3232-3238. PubMed ID: 28479180
    [Abstract] [Full Text] [Related]

  • 29. Recognition of Plasmodium falciparum mature gametocyte-infected erythrocytes by antibodies of semi-immune adults and malaria-exposed children from Gabon.
    Gebru T, Ajua A, Theisen M, Esen M, Ngoa UA, Issifou S, Adegnika AA, Kremsner PG, Mordmüller B, Held J.
    Malar J; 2017 Apr 26; 16(1):176. PubMed ID: 28446190
    [Abstract] [Full Text] [Related]

  • 30. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
    Burns JM, Miura K, Sullivan J, Long CA, Barnwell JW.
    Malar J; 2016 Mar 15; 15():159. PubMed ID: 26975721
    [Abstract] [Full Text] [Related]

  • 31. Helminth infection impairs the immunogenicity of a Plasmodium falciparum DNA vaccine, but not irradiated sporozoites, in mice.
    Noland GS, Chowdhury DR, Urban JF, Zavala F, Kumar N.
    Vaccine; 2010 Apr 09; 28(17):2917-23. PubMed ID: 20188676
    [Abstract] [Full Text] [Related]

  • 32. IgG2 antibodies against a clinical grade Plasmodium falciparum CSP vaccine antigen associate with protection against transgenic sporozoite challenge in mice.
    Schwenk R, DeBot M, Porter M, Nikki J, Rein L, Spaccapelo R, Crisanti A, Wightman PD, Ockenhouse CF, Dutta S.
    PLoS One; 2014 Apr 09; 9(10):e111020. PubMed ID: 25343487
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Functional characterization of Plasmodium berghei PSOP25 during ookinete development and as a malaria transmission-blocking vaccine candidate.
    Zheng W, Liu F, He Y, Liu Q, Humphreys GB, Tsuboi T, Fan Q, Luo E, Cao Y, Cui L.
    Parasit Vectors; 2017 Jan 05; 10(1):8. PubMed ID: 28057055
    [Abstract] [Full Text] [Related]

  • 35. Impact on malaria parasite multiplication rates in infected volunteers of the protein-in-adjuvant vaccine AMA1-C1/Alhydrogel+CPG 7909.
    Duncan CJ, Sheehy SH, Ewer KJ, Douglas AD, Collins KA, Halstead FD, Elias SC, Lillie PJ, Rausch K, Aebig J, Miura K, Edwards NJ, Poulton ID, Hunt-Cooke A, Porter DW, Thompson FM, Rowland R, Draper SJ, Gilbert SC, Fay MP, Long CA, Zhu D, Wu Y, Martin LB, Anderson CF, Lawrie AM, Hill AV, Ellis RD.
    PLoS One; 2011 Jan 05; 6(7):e22271. PubMed ID: 21799809
    [Abstract] [Full Text] [Related]

  • 36. Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii.
    Zheng L, Pang W, Qi Z, Luo E, Cui L, Cao Y.
    Parasit Vectors; 2016 Aug 08; 9(1):433. PubMed ID: 27502144
    [Abstract] [Full Text] [Related]

  • 37. Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.
    Rouhani M, Zakeri S, Mehrizi AA, Djadid ND.
    Malar J; 2015 Feb 05; 14():58. PubMed ID: 25652589
    [Abstract] [Full Text] [Related]

  • 38. Functional Characterization and Comparison of Plasmodium falciparum Proteins as Targets of Transmission-blocking Antibodies.
    Nikolaeva D, Illingworth JJ, Miura K, Alanine DGW, Brian IJ, Li Y, Fyfe AJ, Da DF, Cohuet A, Long CA, Draper SJ, Biswas S.
    Mol Cell Proteomics; 2020 Jan 05; 19(1):155-166. PubMed ID: 29089373
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.